They express several immune-associated receptors, including Toll-like receptor 4 (TLR4), NLRP3, and the interferon receptor (IFNAR), all of which have attracted increasing interest as potential therapeutic targets for modulating fibrotic responses in CF (Díaz-Araya et al., 2015). The gene discussed is TLR4; the disease is cystic fibrosis.